In the published article, there was an error in Table 6 (Adverse events) as published. The error was found in the percentage of participants with sepsis associated with enteritis in the PEMA group. The corrected table appears below.
Table 6
| PEMA (n = 63) | OMEGA-3 (n = 63) | |
|---|---|---|
| AEs | 9 (14.3) | 3 (4.8) |
| Participants who discontinued treatment because of drug-related AE | ||
| Nausea | 1 (1.6) | 0 (0.0) |
| Pain in the extremities | 1 (1.6) | 0 (0.0) |
| Erythema on the forearm | 1 (1.6) | 0 (0.0) |
| Itching in the forearm | 1 (1.6) | 0 (0.0) |
| General malaise | 1 (1.6) | 0 (0.0) |
| Anorexia | 1 (1.6) | 0 (0.0) |
| Participants who discontinued treatment because of drug-unrelated AE | ||
| Neck stiffness | 1 (1.6) | 0 (0.0) |
| Tooth pain | 1 (1.6) | 0 (0.0) |
| Sepsis associated with enteritis | 1 (1.6) | 0 (0.0) |
| Other AEs | ||
| Worsening of glycemic control | 2 (3.2) | 1 (1.6) |
| Acute epiglottitis | 1 (1.6) | 0 (0.0) |
| Dental caries | 1 (1.6) | 0 (0.0) |
| Liver dysfunction | 1 (1.6) | 0 (0.0) |
| Muscular pain | 1 (1.6) | 0 (0.0) |
| Fall | 0 (0.0) | 1 (1.6) |
| Lumbago | 0 (0.0) | 1 (1.6) |
| Elevation of serum CK | 0 (0.0) | 1 (1.6) |
Adverse events.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
apolipoprotein B-48, atherosclerotic cardiovascular disease, residual risk, hypertriglyceridemia, pemafibrate, polyunsaturated fatty acids
Citation
Takeda Y, Sakuma I, Hiramitsu S, Okada M, Ueda S and Sakurai M (2023) Corrigendum: The effects of pemafibrate and Omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study). Front. Cardiovasc. Med. 10:1172664. doi: 10.3389/fcvm.2023.1172664
Received
23 February 2023
Accepted
02 March 2023
Published
16 March 2023
Volume
10 - 2023
Edited and reviewed by
Ichiro Manabe, Chiba University, Japan
Updates
Copyright
© 2023 Takeda, Sakuma, Hiramitsu, Okada, Ueda and Sakurai.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yasutaka Takeda yktake5@asahikawa-med.ac.jp
Specialty Section: This article was submitted to Cardiovascular Metabolism, a section of the journal Frontiers in Cardiovascular Medicine
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.